BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Sheldon Brookman. Preliminary Findings on the Use of Targeted Therapy in Combination with Sodium Phenylbutyrate in Colorectal Cancer after Failure of Second-Line Therapy—A Potential Strategy for Improved SurvivalJournal of Cancer Therapy 2014; 5(13): 1270 doi: 10.4236/jct.2014.513128
2
Yu-Jia Chang, Chien-Yu Huang, Chin-Sheng Hung, Hui-Hsiung Liu, Po-Li Wei. Glucose-regulated protein 78 mediates the therapeutic efficacy of 17-DMAG in colon cancer cellsTumor Biology 2015; 36(6): 4367 doi: 10.1007/s13277-015-3076-0
3
Karl J. Okolotowicz, Mary Dwyer, Daniel Ryan, Jiongjia Cheng, Emily A. Cashman, Stephanie Moore, Mark Mercola, John R. Cashman. Novel tertiary sulfonamides as potent anti-cancer agentsBioorganic & Medicinal Chemistry 2018; 26(15): 4441 doi: 10.1016/j.bmc.2018.07.042
4
Jeng-Wei Lu, Yi-Jung Ho, Shih-Ci Ciou, Zhiyuan Gong. Innovative Disease Model: Zebrafish as an In Vivo Platform for Intestinal Disorder and TumorsBiomedicines 2017; 5(4): 58 doi: 10.3390/biomedicines5040058
5
Efrat Dotan, Steven J. Cohen, Alexander N. Starodub, Christopher H. Lieu, Wells A. Messersmith, Pamela S. Simpson, Michael J. Guarino, John L. Marshall, Richard M. Goldberg, J. Randolph Hecht, William A. Wegener, Robert M. Sharkey, Serengulam V. Govindan, David M. Goldenberg, Jordan D. Berlin. Phase I/II Trial of Labetuzumab Govitecan (Anti-CEACAM5/SN-38 Antibody-Drug Conjugate) in Patients With Refractory or Relapsing Metastatic Colorectal CancerJournal of Clinical Oncology 2017; 35(29): 3338 doi: 10.1200/JCO.2017.73.9011
6
Rachel M. Lee, Kenneth Cardona, Maria C. Russell. Historical perspective: Two decades of progress in treating metastatic colorectal cancerJournal of Surgical Oncology 2019; 119(5): 549 doi: 10.1002/jso.25431
7
Haneen Amawi, Noor A. Hussein, Charles R. Ashby, Rawan Alnafisah, Leticia M. Sanglard, Elangovan Manivannan, Chandrabose Karthikeyan, Piyush Trivedi, Kathryn M. Eisenmann, Robert W. Robey, Amit K. Tiwari. Bax/Tubulin/Epithelial-Mesenchymal Pathways Determine the Efficacy of Silybin Analog HM015k in Colorectal Cancer Cell Growth and MetastasisFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00520
8
Changfu Qin, Yingmo Shen, Baoshan Wang, Xuefei Zhao, Yiting Liu, Shuo Yang, Jie Chen. An acellular tissue matrix-based drug carriers with dual chemo-agents for colon cancer growth suppressionBiomedicine & Pharmacotherapy 2019; 117: 109048 doi: 10.1016/j.biopha.2019.109048
9
Suk-young Lee, Sang Cheul Oh. Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal CancerBioMed Research International 2016; 2016: 1 doi: 10.1155/2016/7590245
10
Zuzana Kozovska, Veronika Gabrisova, Lucia Kucerova. Colon cancer: Cancer stem cells markers, drug resistance and treatmentBiomedicine & Pharmacotherapy 2014; 68(8): 911 doi: 10.1016/j.biopha.2014.10.019
11
Lene H. Iversen, Anders Green, Peter Ingeholm, Kell Østerlind, Ismail Gögenur. Improved survival of colorectal cancer in Denmark during 2001–2012 – The efforts of several national initiativesActa Oncologica 2016; 55(sup2): 10 doi: 10.3109/0284186X.2015.1131331
12
Jae Hyun Kim, Seun Ja Park. Target Therapy in Unresectable or Metastatic Colorectal CancerThe Korean Journal of Gastroenterology 2016; 68(6): 303 doi: 10.4166/kjg.2016.68.6.303
13
Curt Balch, Jayaram B. Ramapuram, Amit K. Tiwari. The Epigenomics of Embryonic Pathway Signaling in Colorectal CancerFrontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00267